ProtAb For Profit
ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways.
Industry:
Clinical Data Management
Investors Number:
1
Technology:
Biomarker panels
Last Funding Type:
Venture - Series Unknown
Headquarters:
Jerusalem, Yerushalayim, Israel
Founded Date:
1905-06-27
Investor Type:
For Profit
Funding Status:
Early Stage Venture
Estimated Revenue:
Less than $1M
Employee Number:
Jerusalem, Yerushalayim, Israel